semaglutide injection brands US FDA approves weight loss drug Wegovy to prevent cardiovascular events Ozempic (semaglutide) - MedicalMex

Developed by Eli Lilly as a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, retatrutide achieved a mean body weight reduction of -24.2% at its highest dose over 48 weeks surpassing both semaglutide and tirzepatide in their respective pivotal trials

If you want a broader treatment overview, does GLP-1 work

Critics, however, including obesity specialists and pharmaceutical companies, warned these compounded products lacked FDA approval, could be inconsistent in quality, and were linked to alarming health incidents

Before and After: What Results Can You Expect

The table below details the complete chemical footprint of the molecule for validation purposes